<DOC>
	<DOCNO>NCT01610531</DOCNO>
	<brief_summary>Melanoma nowadays important public health problem grow incidence . Mass screen melanoma recommend worldwide low cost-effectiveness . Nevertheless targeted screen patient high risk melanoma promote . This study design assess effectiveness acceptability melanoma target screen melanoma , estimate risk function develop melanoma among patient high risk accord SAMScore estimate ratio cost/ efficacy melanoma target screening . A cohort 7700 patient carry 2 department cover registry cancer . The recruitment begin April 2011 . Patients assess high risk accord SAMScore propose skin examination GP every year .</brief_summary>
	<brief_title>COPARIME : Pilot Study Target Detection Malignant Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>patient 18 year old , consult GP , assess risk melanoma accord SAMScore sign consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Cohort</keyword>
	<keyword>Melanoma</keyword>
	<keyword>target screening</keyword>
	<keyword>risk function</keyword>
	<keyword>cost effectiveness</keyword>
</DOC>